Annereau Maxime, Vignes Marina, Denis Lucas, Rieutord André, Legrand François-Xavier, Rioblanc François, Paul Muriel, Grill Jacques, Secretan Philippe-Henri, Do Bernard
Université Paris-Saclay, 91400 Orsay, France.
Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
Pharmaceutics. 2023 Sep 22;15(10):2371. doi: 10.3390/pharmaceutics15102371.
Glioblastoma is one of the most common and aggressive forms of brain tumor, a rare disease for which there is a great need for innovative therapies. ONC201, a new drug substance, has been used in a compassionate treatment program where the choice of dosage form and regimen have yet to be justified. The prior knowledge needed to anticipate ONC201 stability problems has recently been partially addressed, by (i) showing that ONC201 is sensitive to light and oxidation and (ii) identifying the molecular structures of the main degradation products formed. The aim of the work presented here was to improve our understanding of the degradation pathways of ONC201 using data from ab initio calculations and experimental work to supplement the structural information we already published. The C-H bonds located αto the amine of the tetrahydropyridine group and those located to the imine function of the dihydroimidazole group exhibit the lowest bond dissociation energies (BDEs) within the ONC201 molecule. Moreover, these values drop well below 90 kcal.mol when ONC201 is in an excited state (S1; T1). The structures of the photoproducts we had previously identified are consistent with these data, showing that they would have resulted from radical processes following the abstraction of hydrogens. Concerning ONC201's sensitivity to oxidation, the structures of the oxidation products matched the critical points revealed through mapped electrostatic potential (MEP) and average local ionization energy (ALIE). The data obtained from ab initio calculations and experimental work showed that the reactivity of ONC201 to light and oxidation conditions is highly dependent on pH. While an acidic environment (pH < 6) contributes to making ONC201 quantitatively more stable in solution in the face of oxidation and photo-oxidation, it nevertheless seems that certain chemical groups in the molecule are more exposed to nucleophilic attacks, which explains the variation observed in the profile of degradation products formed in the presence of certain antioxidants tested. This information is crucial to better understand the stability results in the presence of antioxidant agents and to determine the right conditions for them to act.
胶质母细胞瘤是最常见且侵袭性最强的脑肿瘤形式之一,这是一种急需创新疗法的罕见疾病。新药ONC201已被用于一项同情用药治疗项目,但剂型和给药方案的选择仍有待论证。近期,通过以下方式部分解决了预测ONC201稳定性问题所需的先验知识:(i)表明ONC201对光和氧化敏感;(ii)确定了形成的主要降解产物的分子结构。本文所呈现工作的目的是利用从头算计算和实验工作的数据,加深我们对ONC201降解途径的理解,以补充我们已发表的结构信息。位于四氢吡啶基团胺基α位的C-H键以及位于二氢咪唑基团亚胺官能团处的C-H键,在ONC201分子中表现出最低的键解离能(BDE)。此外,当ONC201处于激发态(S1;T1)时,这些值远低于90 kcal·mol 。我们之前鉴定的光产物结构与这些数据一致,表明它们是氢原子被夺取后自由基过程的产物。关于ONC201对氧化的敏感性,氧化产物的结构与通过映射静电势(MEP)和平均局部电离能(ALIE)揭示的关键点相匹配。从头算计算和实验工作获得的数据表明,ONC201对光和氧化条件的反应性高度依赖于pH值。虽然酸性环境(pH < 6)有助于使ONC201在面对氧化和光氧化时在溶液中更具定量稳定性,但分子中的某些化学基团似乎更容易受到亲核攻击,这解释了在测试的某些抗氧化剂存在下形成的降解产物谱中观察到的变化。这些信息对于更好地理解抗氧化剂存在时的稳定性结果以及确定它们发挥作用的合适条件至关重要。